Australian Institute of Health and Welfare, Cancer in Australia 2017. Cancer series no. 101.Cat. no. CAN 100. 2017. AIHW: Canberra
Hamel, J.-F., et al. (2016). A systematic review examining factors influencing health related quality of life among melanoma cancer survivors. European Journal of Cancer,69, 189–198.
Beutel, M. E., et al. (2015). Depression, anxiety and quality of life in long-term survivors of malignant melanoma: A register-based cohort study. PLoS ONE,10(1), e0116440.
Costa, D. S., et al. (2016). Psychometric properties of the Fear of Cancer Recurrence Inventory: An item response theory approach. Psychooncology,25(7), 832–838.
Kasparian, N. A., McLoone, J. K., & Butow, P. N. (2009). Psychological responses and coping strategies among patients with malignant melanoma: A systematic review of the literature. Archives of Dermatology,145(12), 1415–1427.
Glaser, A. W., et al. (2013). Patient-reported outcomes of cancer survivors in England 1–5 years after diagnosis: A cross-sectional survey. British Medical Journal Open,3(4), e002317.
Jefford, M., et al. (2017). Patient-reported outcomes in cancer survivors: A population-wide cross-sectional study. Supportive Care in Cancer,25, 3171–3179.
Social Research Centre, Dual-frame omnibus survey: Technical and methodological summary report. Internal report. 2012: https://www.srcentre.com.au/docs/event-workshop-july-2012/dual-frame-omnibus-technical-report-%28pennay%29.pdf?sfvrsn=2.
EuroQoL Group. (2013). EQ-5D-5L user guide.
Norman, R., Cronin, P., & Viney, R. (2013). A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states. Applied Health Economics and Health Policy,11(3), 287–298.
Lumley, T., Survey: Analysis of complex survey samples. R package version 3.30. 2014.
Winstanley, J. B., et al. (2015). Cross-cultural development of a quality-of-life measure for patients with melanoma: Phase 3 testing of an EORTC Melanoma Module. Melanoma Research,25(1), 47–58.
Winstanley, J. B., et al. (2013). What are the pertinent quality-of-life issues for melanoma cancer patients? Aiming for the development of a new module to accompany the EORTC core questionnaire. Melanoma Research,23(2), 167–174.
Kasparian, N. A., et al. (2016). "Melanoma: Questions and answers." Development and evaluation of a psycho-educational resource for people with a history of melanoma. Supportive Care in Cancer,24(12), 4849–4859.
Dieng, M., et al. (2016). Psychoeducational intervention to reduce fear of cancer recurrence in people at high risk of developing another primary melanoma: Results of a randomized controlled trial. Journal of Clinical Oncology,34(36), 4405–4414.
McLoone, J., et al. (2012). When the risks are high: Psychological adjustment among melanoma survivors at high risk of developing new primary disease. Qualitative Health Research,22(8), 1102–1113.
Vogel, R. I., et al. (2017). Comparison of quality of life among long-term melanoma survivors and non-melanoma controls: A cross-sectional study. Quality of Life Research,26(7), 1761–1766.
Holterhues, C., et al. (2011). Impact of melanoma on patients' lives among 562 survivors: A Dutch population-based study. Archives of Dermatology,147(2), 177–185.
Branstrom, R., et al. (2010). Predictors of sun protection behaviors and severe sunburn in an international online study. Cancer Epidemiology, Biomarkers & Prevention,19(9), 2199–2210.
Lacey, K., et al. (2016). Presentations to general practice before a cancer diagnosis in Victoria: A cross-sectional survey. Medical Journal of Australia,205(2), 66–71.
Carey, M., et al. (2012). How well are we meeting haematological cancer survivors' preferences for involvement in treatment decision making? Patient Education and Counseling,88(1), 87–92.
Watson, E. K., et al. (2012). Personalised cancer follow-up: Risk stratification, needs assessment or both? British Journal of Cancer,106(1), 1–5.